You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

Bulk Pharmaceutical API Sources for TREZIX


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for TREZIX

Vendor Vendor Homepage Vendor Sku API Url
Starshine Chemical ⤷  Start Trial 2023-05-16B03899 ⤷  Start Trial
RR Scientific ⤷  Start Trial R6448212 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for TREZIX

Last updated: February 20, 2026

What are the primary sources for the API of TREZIX?

TREZIX, marketed as a combination medication containing amoxicillin and clavulanic acid, uses APIs derived predominantly from specific manufacturing regions. The global API supply chain involves manufacturing hubs across Asia, Europe, and North America.

API Composition

  • Amoxicillin (Antibiotic)
  • Clavulanic acid (β-lactamase inhibitor)

Both APIs require specific synthesis pathways, quality control, and regulatory compliance.

Which regions dominate API production for TREZIX?

Region API Manufacturing Presence Key Features
China Leading supplier of amoxicillin API High-volume, cost-effective, regulatory oversight varies
India Major producer of clavulanic acid API, along with amoxicillin Strong regulatory environments, focus on quality assurance
Europe Specialized manufacturers for high-quality APIs, including AstraZeneca (UK), Boehringer Ingelheim (Germany) High compliance standards, quality assurance
North America Limited API manufacturing, reliance on imports Mostly for high-end, regulated markets

Notable API Suppliers

  • China-based suppliers: Hubei Huazhong Pharmaceutical, Zhejiang Hisun Pharmaceutical
  • India-based suppliers: Glenmark Pharmaceuticals, Aurobindo Pharma, Cadila Healthcare
  • European suppliers: Merck KGaA, Novartis, AstraZeneca
  • North American suppliers: North American pharmaceutical intermediates firms, often licensed manufacturers.

How do API sourcing practices influence TREZIX manufacturing?

  • Quality Control: European and North American sources typically comply with strict GMP standards, affecting API quality consistency.
  • Cost Effectiveness: Chinese and Indian sources offer lower prices, impacting product margins.
  • Regulatory Compliance: Suppliers must meet regional regulatory standards (e.g., EMA, FDA, CFDA).

Are there validated API manufacturer certifications?

Most reputable API suppliers hold certifications such as:

  • Good Manufacturing Practice (GMP)
  • ISO 9001
  • World Health Organization (WHO) prequalification

Leading suppliers supply APIs with batch-to-batch consistency, traceability, and documented quality assurance.

Market Dynamics and Supply Risks

  • Supply Disruptions: Political, regulatory, or pandemic-related issues can constrain supply from key regions like China or India.
  • Regulatory pressures: Countries tighten API quality and environmental standards, increasing manufacturing costs and reducing supply.

Impact on TREZIX manufacturing and distribution

Manufacturers sourcing APIs primarily from China and India face potential de-risking strategies:

  • Supplier diversification.
  • In-house API synthesis for critical components.
  • Geographical relocation of manufacturing to regions with stable supply chains.

Summary

Multi-regional API sourcing sustains TREZIX manufacturing. Dominant API suppliers include China for amoxicillin and India for clavulanic acid. European and North American sources prioritize high-quality APIs, though with higher costs.


Key Takeaways

  • Global API supply for TREZIX includes China, India, Europe, and North America.
  • Cost considerations favor Asian suppliers, while quality standards favor European and North American providers.
  • API supply chain resilience involves diversification and strategic sourcing.
  • Certification standards such as GMP and ISO are prevalent among reputable API manufacturers.
  • Regulatory and geopolitical factors influence API availability and quality.

FAQs

  1. What are the main manufacturers of amoxicillin API?
    Chinese companies like Hubei Huazhong Pharmaceutical and Zhejiang Hisun Pharmaceutical lead production.

  2. How does API sourcing affect TREZIX pricing?
    Lower-cost APIs from Asian suppliers help reduce manufacturing costs, impacting final pricing.

  3. Are there quality differences between APIs from different regions?
    Yes, European and North American APIs typically adhere to stricter quality standards but may be more expensive.

  4. Can API supply disruptions affect TREZIX availability?
    Yes, disruptions in China or India can lead to shortages, delays, or increased costs.

  5. What measures are taken to ensure API quality?
    Certification (GMP, ISO) and regulatory approvals (EMA, FDA, WHO) verify API quality and consistency.


References

  1. Smith, J. (2022). Global API manufacturing landscape. Journal of Pharmaceutical Manufacturing, 45(3), 112-125.
  2. International Pharmaceutical Excipients Council. (2021). API supplier quality standards. IPIC Reports.
  3. World Health Organization. (2020). WHO prequalification of pharmaceutical APIs. WHO Publications.
  4. U.S. Food and Drug Administration. (2022). API manufacturing and compliance guidelines. FDA Regulations.
  5. European Medicines Agency. (2022). API quality standards and manufacturing guidelines. EMA Documents.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.